1. Yinghuan Li, Xi Tan, Xuhan Liu, Lingyan Liu, Yan Fang, Rong Rao, Yuanyuan Ren, Xiangliang Yang and Wei Liu*.Enhanced anticancer effect of doxorubicin by TPGS-coated liposomes with Bcl-2 siRNA-corona for dual suppression of drug resistance..Asian Journal of Pharmaceutical Sciences. .2020.15.646-660.SCI |
2. Liu Xuhan, Li Yinghuan*, Tan Xi, Rao Rong, Ren Yuanyuan, Liu Lingyan, Yang Xiangliang, Liu Wei*.Multifunctional hybrid micelles with tunable active targeting and acid/phosphatase-stimulated drug release for enhanced tumor suppression..Biomaterials.2018.157.136-148.SCI |
3. Liu Xuhan#, Tan Xi#, Rao Rong, Ren Yuanyuan, Li Yinghuan*, Yang Xiangliang, Liu Wei*.Self-assembled PAEEP-PLLA micelles with varied hydrophilic block lengths for tumor cell targeting..ACS Appl. Mater. Interfaces.2016.8(36).23450-23462.SCI |
4. Li Yinghuan, Gao Lei, Tan Xi, Li Feiyang, Zhao MIng*, Peng Shiqi*.Lipid rafts-mediated endocytosis and physiology-based cell membrane traffic models of doxorubicin liposomes..Biochim. Biophys. Acta-Biomembranes.2016.1858(8).1801-1811.SCI |
5. Li Yinghuan#, Zheng Xuelian#, Sun Yi, Ren Zhao, Li Xuemei, Cui Guohui*.RGD-fatty alcohol-modified docetaxel liposomes improve tumor selectivity in vivo..Int. J. Pharm..2014.468.133-141.SCI |
6. Li Yinghuan, Wang Jie, Wientjes M Guillaume, Au Jessie L-S*.Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor..Adv. Drug Deliv. Rev..2012.64(1).29-39.SCI |
7. Li Yinghuan*, Zhu Jiabi.Modulation of combined-release behaviors from a novel “tablets-in-capsule system”..J. Controlled Rel..2004.95(3).381-389.SCI |